Rolf T. Urbanus

Associate professor
Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

Presentation(s):

• PB0078 - Lupus anticoagulant as predictor for thrombosis in critically ill COVID-19 patients: a retrospective cohort study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0415 - The effect of a gut microbiome intervention on antiphospholipid syndrome: the ROMAS study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 32.3 - Anti-β2-glycoprotein I antibodies cause activated protein C resistance by interfering with Factor V cleavage at Arginine 506

  Monday, July 11, 2022
  11:15 AM – 11:30 AM

• PB0578 - Generation and characterization of novel nanobodies inhibiting factor XI function

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0631 - VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0719 - The novel bispecific antibody HMB-001 enhances the haemostatic response in models of Glanzmann Thrombasthenia by targeting FVIIa to activated platelets

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0780 - Patients with multiple myeloma have an increased prevalence of acquired platelet secretion defects and a disbalanced whole blood thrombin generation profile

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0862 - Platelet activation via glycoprotein VI initiates thrombin generation: a potential role for platelet-derived factor IX?

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1214 - Effect of eltrombopag on platelet receptor expression and activation in patients with immune thrombocytopenia

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM